114 related articles for article (PubMed ID: 9324283)
1. Myeloproliferative disease and myelodysplastic syndrome induced by transplantation of bone marrow cells expressing mutant p53.
Shounan Y; MacKenzie K; Dolnikov A; Miller M; Symonds G
Leukemia; 1997 Oct; 11(10):1641-9. PubMed ID: 9324283
[TBL] [Abstract][Full Text] [Related]
2. Retroviral transduction of hematopoietic progenitor cells with mutant p53 promotes survival and proliferation, modifies differentiation potential and inhibits apoptosis.
Shounan Y; Dolnikov A; MacKenzie KL; Miller M; Chan YY; Symonds G
Leukemia; 1996 Oct; 10(10):1619-28. PubMed ID: 8847897
[TBL] [Abstract][Full Text] [Related]
3. Retroviral-mediated transfer of the murine interleukin-3 gene engineered for intracellular retention results in a myeloproliferative syndrome but is associated with circulating interleukin-3 levels.
Orchard PJ; Detrick RA; Gorden K; Dunbar CE; Vallera DA; Taylor P; McIvor RS; Blazar BR
Exp Hematol; 1993 Aug; 21(9):1245-54. PubMed ID: 8330649
[TBL] [Abstract][Full Text] [Related]
4.
Smeets MF; Tan SY; Xu JJ; Anande G; Unnikrishnan A; Chalk AM; Taylor SR; Pimanda JE; Wall M; Purton LE; Walkley CR
Blood; 2018 Aug; 132(6):608-621. PubMed ID: 29903888
[TBL] [Abstract][Full Text] [Related]
5. Mutant N-ras induces myeloproliferative disorders and apoptosis in bone marrow repopulated mice.
MacKenzie KL; Dolnikov A; Millington M; Shounan Y; Symonds G
Blood; 1999 Mar; 93(6):2043-56. PubMed ID: 10068678
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.
Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V
Clin Exp Pathol; 1999; 47(5):231-8. PubMed ID: 10598372
[TBL] [Abstract][Full Text] [Related]
7. Tolerance by selective in vivo expansion of foreign major histocompatibility complex-transduced autologous bone marrow.
Zhang JL; Cai J; Walls S; Jackson JD; Kuszynski CA; Zhao Y; Pawliuk R; Leboulch P; Fox IJ
Transplantation; 2005 Aug; 80(3):362-9. PubMed ID: 16082332
[TBL] [Abstract][Full Text] [Related]
8. Germline mutations in the bone marrow microenvironment and dysregulated hematopoiesis.
Miller LH; Qu CK; Pauly M
Exp Hematol; 2018 Oct; 66():17-26. PubMed ID: 30076950
[TBL] [Abstract][Full Text] [Related]
9. Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm.
Nguyen TK; Morse SJ; Fleischman AG
J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060252
[TBL] [Abstract][Full Text] [Related]
10. Direct reversal of DNA damage by mutant methyltransferase protein protects mice against dose-intensified chemotherapy and leads to in vivo selection of hematopoietic stem cells.
Ragg S; Xu-Welliver M; Bailey J; D'Souza M; Cooper R; Chandra S; Seshadri R; Pegg AE; Williams DA
Cancer Res; 2000 Sep; 60(18):5187-95. PubMed ID: 11016647
[TBL] [Abstract][Full Text] [Related]
11. Characterization of murine JAK2V617F-positive myeloproliferative disease.
Bumm TG; Elsea C; Corbin AS; Loriaux M; Sherbenou D; Wood L; Deininger J; Silver RT; Druker BJ; Deininger MW
Cancer Res; 2006 Dec; 66(23):11156-65. PubMed ID: 17145859
[TBL] [Abstract][Full Text] [Related]
12. Asrij/OCIAD1 suppresses CSN5-mediated p53 degradation and maintains mouse hematopoietic stem cell quiescence.
Sinha S; Dwivedi TR; Yengkhom R; Bheemsetty VA; Abe T; Kiyonari H; VijayRaghavan K; Inamdar MS
Blood; 2019 May; 133(22):2385-2400. PubMed ID: 30952670
[TBL] [Abstract][Full Text] [Related]
13. Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.
Lepelley P; Preudhomme C; Vanrumbeke M; Quesnel B; Cosson A; Fenaux P
Leukemia; 1994 Aug; 8(8):1342-9. PubMed ID: 8057671
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathology of myelodysplastic syndromes: biology of medullary stromal and hematopoietic cells (review).
Kitagawa M; Kurata M; Yamamoto K; Abe S; Suzuki S; Umeda S
Mol Med Rep; 2011; 4(4):591-6. PubMed ID: 21584497
[TBL] [Abstract][Full Text] [Related]
15. Clonality studies and N-ras and p53 mutation analysis of hematopoietic cells in Fanconi anemia.
Venkatraj VS; Gaidano G; Auerbach AD
Leukemia; 1994 Aug; 8(8):1354-8. PubMed ID: 8057673
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the p53 gene in myelodysplastic syndromes.
Jonveaux P; Fenaux P; Quiquandon I; Pignon JM; Laï JL; Loucheux-Lefebvre MH; Goossens M; Bauters F; Berger R
Oncogene; 1991 Dec; 6(12):2243-7. PubMed ID: 1766671
[TBL] [Abstract][Full Text] [Related]
17. FHIT gene transcript alterations occur frequently in myeloproliferative and myelodysplastic diseases.
Luan X; Ramesh KH; Cannizzaro LA
Cytogenet Cell Genet; 1998; 81(3-4):183-8. PubMed ID: 9730598
[TBL] [Abstract][Full Text] [Related]
18. Structural integrity and expression of the L3MBTL gene in normal and malignant hematopoietic cells.
MacGrogan D; Kalakonda N; Alvarez S; Scandura JM; Boccuni P; Johansson B; Nimer SD
Genes Chromosomes Cancer; 2004 Nov; 41(3):203-13. PubMed ID: 15334543
[TBL] [Abstract][Full Text] [Related]
19. In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders.
Greenberg PL
Clin Haematol; 1986 Nov; 15(4):973-93. PubMed ID: 3552351
[No Abstract] [Full Text] [Related]
20. Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene.
Murakami T; Tokunaga N; Waku T; Gomi S; Kagawa S; Tanaka N; Fujiwara T
Clin Cancer Res; 2004 Jun; 10(11):3871-80. PubMed ID: 15173096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
